Hein J Boot

Summary

Affiliation: National Institute for Public Health and the Environment
Country: The Netherlands

Publications

  1. ncbi Identification, phenotypic analysis, and full-length nucleotide sequence of a Dutch Coxsackievirus A20 isolate
    Hein J Boot
    Laboratory of Vaccine Preventable Diseases, National Institute for Public Health and the Environment RIVM, P O Box 1, 3720 BA, Bilthoven, The Netherlands
    Virus Genes 34:75-85. 2007
  2. ncbi [Vaccination against pneumococci and hepatitis B in the Dutch National Immunisation Programme]
    H J Boot
    Rijksinstituut voor Volksgezondheid en Milieu RIVM, Centrum Infectieziektebestrijding CIb, Postbus I, 3720 BA Bilthoven
    Ned Tijdschr Geneeskd 151:172-6. 2007
  3. ncbi Assessing the introduction of universal varicella vaccination in the Netherlands
    Hein J Boot
    Laboratory of Vaccine Preventable Diseases, National Institute for Public Health and the Environment RIVM, P O Box 1, 3720 BA Bilthoven, The Netherlands
    Vaccine 24:6288-99. 2006
  4. ncbi Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands
    Hein J Boot
    Laboratory for Infectious Diseases and Perinatal Screening, RIVM, Bilthoven, The Netherlands
    Vaccine 25:6245-56. 2007
  5. ncbi The enhanced virulence of very virulent infectious bursal disease virus is partly determined by its B-segment
    H J Boot
    Animal Sciences Group, Wageningen University and Research Centre, Lelystad, The Netherlands
    Arch Virol 150:137-44. 2005
  6. ncbi Improved tracing of hepatitis B virus transmission chains by phylogenetic analysis based on C region sequences
    Hein J Boot
    Laboratory for Infectious Diseases and Perinatal Screening, National Institute for Public Health and the Environment RIVM, Bilthoven, The Netherlands
    J Med Virol 80:233-41. 2008
  7. ncbi [Protection of children born to hepatitis-B-infected mothers]
    H J Boot
    Rijksinstituut voor Volksgezondheid en Milieu, Laboratorium voor Toetsing van het Rijksvaccinatieprogramma, Postbus 1, 3720 BA Bilthoven
    Ned Tijdschr Geneeskd 148:1816-8. 2004
  8. pmc Modifications of the 3'-UTR stem-loop of infectious bursal disease virus are allowed without influencing replication or virulence
    Hein J Boot
    Animal Sciences Group, Wageningen University and Research Centre, Lelystad, The Netherlands
    Nucleic Acids Res 32:211-22. 2004
  9. ncbi Rapid RT-PCR amplification of full-length poliovirus genomes allows rapid discrimination between wild-type and recombinant vaccine-derived polioviruses
    Hein J Boot
    Laboratory of Vaccine Preventable Diseases, National Institute for Public Health and the Environment RIVM, PO Box 1, 3720 BA Bilthoven, The Netherlands
    J Virol Methods 116:35-43. 2004
  10. ncbi [Objective registration and interpretation of adverse events caused by vaccines: an essential element of vaccination]
    H J Boot
    Rijksinstituut voor Volksgezondheid en Milieu, Centrum Infectieziekte bestrijding, Postbus 1, 3720 BA Bilthoven
    Ned Tijdschr Geneeskd 151:2707-8. 2007

Collaborators

Detail Information

Publications34

  1. ncbi Identification, phenotypic analysis, and full-length nucleotide sequence of a Dutch Coxsackievirus A20 isolate
    Hein J Boot
    Laboratory of Vaccine Preventable Diseases, National Institute for Public Health and the Environment RIVM, P O Box 1, 3720 BA, Bilthoven, The Netherlands
    Virus Genes 34:75-85. 2007
    ..On the basis of the phylogenetic analysis of the P2 and P3 region we expect that strain 89490 can act as recombination partner for the attenuated poliovirus strains of the Oral Polio Vaccine (OPV)...
  2. ncbi [Vaccination against pneumococci and hepatitis B in the Dutch National Immunisation Programme]
    H J Boot
    Rijksinstituut voor Volksgezondheid en Milieu RIVM, Centrum Infectieziektebestrijding CIb, Postbus I, 3720 BA Bilthoven
    Ned Tijdschr Geneeskd 151:172-6. 2007
    ..This will also generate greater insight into the efficacy of the different vaccination schemes and intervention programmes to prevent vertical transmission of the virus...
  3. ncbi Assessing the introduction of universal varicella vaccination in the Netherlands
    Hein J Boot
    Laboratory of Vaccine Preventable Diseases, National Institute for Public Health and the Environment RIVM, P O Box 1, 3720 BA Bilthoven, The Netherlands
    Vaccine 24:6288-99. 2006
    ..Despite these uncertainties it is clear that universal childhood vaccination will prevent most of the varicella related GP-visits, hospitalizations, and deaths...
  4. ncbi Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands
    Hein J Boot
    Laboratory for Infectious Diseases and Perinatal Screening, RIVM, Bilthoven, The Netherlands
    Vaccine 25:6245-56. 2007
    ....
  5. ncbi The enhanced virulence of very virulent infectious bursal disease virus is partly determined by its B-segment
    H J Boot
    Animal Sciences Group, Wageningen University and Research Centre, Lelystad, The Netherlands
    Arch Virol 150:137-44. 2005
    ..Insight into the virulence factors of very virulent IBDV will contribute to the improvement of live IBDV vaccines...
  6. ncbi Improved tracing of hepatitis B virus transmission chains by phylogenetic analysis based on C region sequences
    Hein J Boot
    Laboratory for Infectious Diseases and Perinatal Screening, National Institute for Public Health and the Environment RIVM, Bilthoven, The Netherlands
    J Med Virol 80:233-41. 2008
    ..Defining the goals of molecular typing of HBV isolates should precede the choice for phylogenetic analysis on the basis of either C or S region sequences...
  7. ncbi [Protection of children born to hepatitis-B-infected mothers]
    H J Boot
    Rijksinstituut voor Volksgezondheid en Milieu, Laboratorium voor Toetsing van het Rijksvaccinatieprogramma, Postbus 1, 3720 BA Bilthoven
    Ned Tijdschr Geneeskd 148:1816-8. 2004
    ....
  8. pmc Modifications of the 3'-UTR stem-loop of infectious bursal disease virus are allowed without influencing replication or virulence
    Hein J Boot
    Animal Sciences Group, Wageningen University and Research Centre, Lelystad, The Netherlands
    Nucleic Acids Res 32:211-22. 2004
    ..Apparently, it is the stem-loop structure and not the primary sequence that is the functional determinant in the 3'-UTRs of IBDV...
  9. ncbi Rapid RT-PCR amplification of full-length poliovirus genomes allows rapid discrimination between wild-type and recombinant vaccine-derived polioviruses
    Hein J Boot
    Laboratory of Vaccine Preventable Diseases, National Institute for Public Health and the Environment RIVM, PO Box 1, 3720 BA Bilthoven, The Netherlands
    J Virol Methods 116:35-43. 2004
    ....
  10. ncbi [Objective registration and interpretation of adverse events caused by vaccines: an essential element of vaccination]
    H J Boot
    Rijksinstituut voor Volksgezondheid en Milieu, Centrum Infectieziekte bestrijding, Postbus 1, 3720 BA Bilthoven
    Ned Tijdschr Geneeskd 151:2707-8. 2007
    ....
  11. ncbi Simultaneous vaccination with Prevenar and multicomponent vaccines for children: interference or no interference?
    Hein J Boot
    Laboratory for Infectious Diseases and Perinatal Screening, Centre for Infectious Diseases Control Netherlands, National Institute for Public Health and the Environment, RIVM, Bilthoven, The Netherlands
    Hum Vaccin 5:15-7. 2009
    ..We advocate better assessment of potential interferences in immune responses after simultaneous vaccinations. Registration of new vaccines should include this assessment...
  12. pmc Excretion of wild-type and vaccine-derived poliovirus in the feces of poliovirus receptor-transgenic mice
    Hein J Boot
    Laboratory for Vaccine Preventable Diseases, National Institute for Public Health and the Environment RIVM, P O Box 1, 3720 BA Bilthoven, The Netherlands
    J Virol 77:6541-5. 2003
    ..This mouse model will be helpful in elucidating the genetic determinants for the high fecal-oral transmission phenotype of cVDPV strains...
  13. doi Acute hepatitis B in a healthcare worker: a case report of genuine vaccination failure
    Hein J Boot
    Centre for Infectious Disease Control, National Institute of Public Health and the Environment RIVM, Bilthoven, The Netherlands
    J Hepatol 50:426-31. 2009
    ....
  14. doi Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination
    H J Boot
    Laboratory for Infectious Diseases and Perinatal Screening, Dutch Centre for Infectious Diseases Control, National Institute for Public Health and the Environment RIVM, Bilthoven, The Netherlands
    J Viral Hepat 17:872-8. 2010
    ..In a programmatic setting, all children born to HBV-infected mothers should be tested not only for the level of anti-HBs but also for the absence of HBsAg, because 2 of the 12 HBV-infected children (17%) had a high level of anti-HBs...
  15. ncbi Determinants of monovalent oral polio vaccine mutagenesis in vaccinated elderly people
    Hein J Boot
    Laboratory of Vaccine Preventable Diseases, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
    Vaccine 25:4706-14. 2007
    ..Duration of excretion appears to be the dominant factor for the accumulation of mutations in mOPV-derived strains in vaccinated elderly people...
  16. pmc Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The Netherlands
    Mirte Scherpenisse
    Laboratory for Infectious Diseases and Screening, National Institute of Public Health and the Environment, Bilthoven, The Netherlands
    PLoS ONE 7:e48807. 2012
    ....
  17. doi Molecular sequence data of hepatitis B virus and genetic diversity after vaccination
    W Marijn van Ballegooijen
    RIVM, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
    Am J Epidemiol 170:1455-63. 2009
    ..The authors argue that molecular sequence data provide a powerful additional monitoring instrument, next to conventional case registration, for assessing the impact of vaccination...
  18. doi Seroprevalence of seven high-risk HPV types in The Netherlands
    Mirte Scherpenisse
    Laboratory for Infectious Diseases and Screening, National Institute of Public Health and the Environment, Bilthoven, The Netherlands
    Vaccine 30:6686-93. 2012
    ..To obtain insight into the age-specific seroprevalence for seven high-risk human papillomavirus (hr-HPV) serotypes (HPV16, 18, 31, 33, 45, 52, and 58) among the general population in the pre-vaccination era in The Netherlands...
  19. pmc Patterns of human papillomavirus DNA and antibody positivity in young males and females, suggesting a site-specific natural course of infection
    Henrike J Vriend
    Centre for Infectious Disease Control, National Institute for Public Health and the Environment, RIVM, Bilthoven, The Netherlands
    PLoS ONE 8:e60696. 2013
    ..Here, we analyze baseline type-specific HPV DNA and HPV-specific antibody positivity rates...
  20. doi Hepatitis C virus seroprevalence in the Netherlands
    Henrike J Vriend
    National Institute for Public Health and the Environment, Center for Infectious Disease Control, Bilthoven, The Netherlands
    Eur J Public Health 22:819-21. 2012
    ..30% (95% confidence interval 0.05-0.55%). About 70% of the HCV positive individuals found were born in an HCV-endemic country...
  21. ncbi Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs
    Tjeerd G Kimman
    Laboratory for Vaccine Preventable Diseases, National Institute of Public Health and the Environment, P O Box 1, 3720 BA Bilthoven, The Netherlands
    Vaccine 24:4769-78. 2006
    ..In the latter case one might be responsible for vaccine-preventable disease and mortality...
  22. doi Air travel as a risk factor for introduction of measles in a highly vaccinated population
    Robert S van Binnendijk
    National Institute for Public Health and the Environment, Bilthoven, The Netherlands
    Vaccine 26:5775-7. 2008
    ....
  23. ncbi [Hepatitis B surveillance in the Netherlands, 2002-2005: acute infection is mainly via sexual contact while chronic infection is via vertical transmission through mothers from endemic regions]
    F D H Koedijk
    Rijksinstituut voor Volksgezondheid en Milieu, Centrum voor Infectieziekten Epidemiologie, Postbus 1, 3720 BA Bilthoven
    Ned Tijdschr Geneeskd 151:2389-94. 2007
    ..To study the trends in the prevalence of hepatitis B infections in the Netherlands on the basis of reported cases...
  24. pmc Rescue of very virulent and mosaic infectious bursal disease virus from cloned cDNA: VP2 is not the sole determinant of the very virulent phenotype
    H J Boot
    Department of Avian Virology, Institute for Animal Science and Health, Lelystad, The Netherlands
    J Virol 74:6701-11. 2000
    ..However, the very virulent phenotype was not solely determined by this protein, since mosaic virus containing VP2 of vvIBDV induced neither morbidity nor mortality in young chickens...
  25. pmc Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands
    Alies van Lier
    Department of Epidemiology and Surveillance, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
    BMC Health Serv Res 10:237. 2010
    ....
  26. doi Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008
    Bianca E P Snijders
    Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
    Vaccine 30:2999-3002. 2012
    ..Our study indicates that the mumps component of the MMR vaccine offered adequate protection against mumps among schoolchildren. The relatively low VE among household contacts is of concern...
  27. ncbi VP1, the RNA-dependent RNA polymerase and genome-linked protein of infectious bursal disease virus, interacts with the carboxy-terminal domain of translational eukaryotic initiation factor 4AII
    M G J Tacken
    Animal Sciences Group, Division Infectious Diseases, Lelystad, The Netherlands
    Arch Virol 149:2245-60. 2004
    ..The biological relevance of the potential VP1-eIF4AII interaction is discussed...
  28. ncbi Comparison of RNA and cDNA transfection methods for rescue of infectious bursal disease virus
    H J Boot
    Department of Avian Virology, Institute for Animal Science and Health, ID Lelystad, PO Box 65, NL 8200 AB, Lelystad, The Netherlands
    J Virol Methods 97:67-76. 2001
    ....
  29. ncbi Rescue of infectious bursal disease virus from mosaic full-length clones composed of serotype I and II cDNA
    H J Boot
    Institute for Animal Science and Health, Department of Avian Virology, Lelystad, The Netherlands
    Arch Virol 146:1991-2007. 2001
    ..These findings make the use of a chimeric VP3 a promising approach to develop an IBDV marker vaccine...
  30. ncbi Efficient rescue of infectious bursal disease virus from cloned cDNA: evidence for involvement of the 3'-terminal sequence in genome replication
    H J Boot
    Department of Avian Virology, Institute for Animal Science and Health, Lelystad, The Netherlands
    Virology 265:330-41. 1999
    ..The rescued viruses from cDNAs containing 3'-terminal deletions appeared to have a restored 3'-terminal sequence. The missing nucleotides are probably restored by using complementary bases of a stem-loop structure as template...
  31. ncbi Homotypic interactions of the infectious bursal disease virus proteins VP3, pVP2, VP4, and VP5: mapping of the interacting domains
    Mirriam G J Tacken
    Institute for Animal Science and Health ID Lelystad B V, Division of Infectious Diseases and Food Chain Quality, P O Box 65, NL 8200 AB Lelystad, The Netherlands
    Virology 312:306-19. 2003
    ..Finally, one interaction domain was detected in the central, most hydrophobic region of VP5, supporting the idea that this virulence determinant may function as a membrane pore-forming protein in infected cells...
  32. pmc Ability of Lactococcus lactis to export viral capsid antigens: a crucial step for development of live vaccines
    Yakhya Dieye
    Useful Bacterial Surface Proteins, INRA URLGA, 78352 Jouy en Josas Cedex, France
    Appl Environ Microbiol 69:7281-8. 2003
    ..The chickens did not develop any detectable immune response against VP2 and VP3 but did exhibit an immune response against Nuc when Nuc-VP2 was anchored to the cell wall of lactococci...
  33. pmc Exchange of the C-terminal part of VP3 from very virulent infectious bursal disease virus results in an attenuated virus with a unique antigenic structure
    Hein J Boot
    Institute for Animal Science and Health, ID Lelystad, PO Box 65, NL 8200 AB Lelystad, The Netherlands
    J Virol 76:10346-55. 2002
    ..We are currently evaluating the potential of this recombinant strain as an attenuated live vaccine that induces a unique serological response (i.e., an IBDV marker vaccine)...
  34. pmc Infectious bursal disease virus capsid protein VP3 interacts both with VP1, the RNA-dependent RNA polymerase, and with viral double-stranded RNA
    Mirriam G J Tacken
    Division of Infectious Diseases and Food Chain Quality, Institute for Animal Science and Health ID Lelystad B V, NL 8200 AB Lelystad, The Netherlands
    J Virol 76:11301-11. 2002
    ..VP3 seems to be the key organizer of birnavirus structure, as it maintains critical interactions with all components of the viral particle: itself, VP2, VP1, and the two genomic dsRNAs...